Experimental prostate cancer therapy delays disease in ‘landmark’ trial

An experimental prostate cancer therapy may change the way patients are treated for the second-deadliest cancer in men. (CNN) — An experimental prostate cancer therapy may change the way patients are treated for the second-deadliest cancer in men. In a “landmark” phase III clinical trial, presented at the European […]

Leave a Reply